Zebrafish as an Emerging Model for Dyslipidemia and Associated Diseases

키워드

참고문헌 (75)

1. Lozano R, "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010 : a systematic analysis for the Global Burden of Disease Study 2010", Lancet, 380, pp.2095~2128 (2012)
2. Phan J, "Hyperlipidemia and nonalcoholic steatohepatitis predispose to hepatocellular carcinoma development without cirrhosis", J Clin Gastroenterol, 53, pp.309~313 (2019)
3. Ishibashi S, "The two-receptor model of lipoprotein clearance : tests of the hypothesis in"knockout"mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins", Proc Natl Acad Sci U S A, 91, pp.4431~4435 (1994)
4. Havel RJ, "Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency", J Clin Invest, 66, pp.1351~1362 (1980)
5. Bertolini S, "Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype", Arterioscler Thromb Vasc Biol, 20, pp.E41~ (2000)
6. LaBrecque DR, "World Gastroenterology Organisation global guidelines : nonalcoholic fatty liver disease and nonalcoholic steatohepatitis", J Clin Gastroenterol, 48, pp.467~473 (2014)
7. Farzadfar F, "National, regional, and global trends in serum total cholesterol since 1980 : systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants", Lancet, 377, pp.578~586 (2011)
8. Fang L, "Zebrafish models of dyslipidemia : relevance to atherosclerosis and angiogenesis", Transl Res, 163, pp.99~108 (2014)
9. Schlegel A, "Zebrafish models for dyslipidemia and atherosclerosis research", Front Endocrinol(Lausanne), 7, pp.159~ (2016)
10. Sæle Ø, "A novel system to quantify intestinal lipid digestion and transport", Biochim Biophys Acta Mol Cell Biol Lipids, 1863, pp.948~957 (2018)
11. Anderson JL, "Zebrafish lipid metabolism : from mediating early patterning to the metabolism of dietary fat and cholesterol", Methods Cell Biol, 101, pp.111~141 (2011)
12. Minchin JE, "In vivo imaging and quantification of regional adiposity in zebrafish", Methods Cell Biol, 138, pp.3~27 (2017)
13. Minchin JE, "A classification system for zebrafish adipose tissues", Dis Model Mech, 10, pp.797~809 (2017)
14. Nüsslein-Volhard C, "The zebrafish issue of development", Development, 139, pp.4099~4103 (2012)
15. Langdon YG, "Maternal and zygotic control of zebrafish dorsoventral axial patterning", Annu Rev Genet, 45, pp.357~377 (2011)
16. Thisse C, "Organogenesis--heart and blood formation from the zebrafish point of view", Science, 295, pp.457~462 (2002)
17. Sehnert AJ, "A window to the heart : can zebrafish mutants help us understand heart disease in humans?", Trends Genet, 18, pp.491~494 (2002)
18. Stainier DY, "A glimpse into the molecular entrails of endoderm formation", Genes Dev, 16, pp.893~907 (2002)
19. Warga RM, "The guts of endoderm formation", Results Probl Cell Differ, 40, pp.28~47 (2002)
20. Sung YH, "Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases", Genome Res, 24, pp.125~131 (2014)
21. Sander JD, "Targeted gene disruption in somatic zebrafish cells using engineered TALENs", Nat Biotechnol, 29, pp.697~698 (2011)
22. Sander JD, "Selection-free zinc-fingernuclease engineering by context-dependent assembly(CoDA)", Nat Methods, 8, pp.67~69 (2011)
23. Zhu C, "Evaluation and application of modularly assembled zinc-finger nucleases in zebrafish", Development, 138, pp.4555~4564 (2011)
24. Howe K, "The zebrafish reference genome sequence and its relationship to the human genome", Nature, 496, pp.498~503 (2013)
25. Liu K, "Expanding the CRISPR toolbox in zebrafish for studying development and disease", Front Cell Dev Biol, 7, pp.13~ (2019)
26. Farber SA, "Genetic analysis of digestive physiology using fluorescent phospholipid reporters", Science, 292, pp.1385~1388 (2001)
27. Landgraf K, "Short-term overfeeding of zebrafish with normal or high-fat diet as a model for the development of metabolically healthy versus unhealthy obesity", BMC Physiol, 17, pp.4~ (2017)
28. Liu C, "Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia", Dis Model Mech, 8, pp.989~998 (2015)
29. Ka J, "Comparison of transcriptomic changes between zebrafish and mice upon high fat diet reveals evolutionary convergence in lipid metabolism", Biochem Biophys Res Commun, 530, pp.638~643 (2020)
30. Babin PJ, "Plasma lipoproteins in fish", J Lipid Res, 30, pp.467~489 (1989)
31. Osborne N, "Lipid receptors in cardiovascular development", Annu Rev Physiol, 65, pp.23~43 (2003)
32. Stoletov K, "Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish", Circ Res, 104, pp.952~960 (2009)
33. Fang L, "Oxidized cholesteryl esters and phospholipids in zebrafish larvae fed a high cholesterol diet : macrophage binding and activation", J Biol Chem, 285, pp.32343~32351 (2010)
34. Otis JP, "Zebrafish as a model for apolipoprotein biology : comprehensive expression analysis and a role for apoA-IV in regulating food intake", Dis Model Mech, 8, pp.295~309 (2015)
35. Tseng WC, "Modeling Niemann-Pick disease type C1 in zebrafish : a robust platform for in vivo screening of candidate therapeutic compounds", Dis Model Mech, 11, pp.dmm034165~ (2018)
36. Liu C, "Deficient cholesterol esterification in plasma of apoc2 knockout zebrafish and familial chylomicronemia patients", PLoS One, 12, pp.e0169939~ (2017)
37. Schlegel A, "Microsomal triglyceride transfer protein is required for yolk lipid utilization and absorption of dietary lipids in zebrafish larvae", Biochemistry, 45, pp.15179~15187 (2006)
38. Avraham-Davidi I, "ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1", Nat Med, 18, pp.967~973 (2012)
39. Quinlivan VH, "Lipid uptake, metabolism, and transport in the larval zebrafish", Front Endocrinol(Lausanne), 8, pp.319~ (2017)
40. Nath AK, "Genetic deletion of gpr27 alters acylcarnitine metabolism, insulin sensitivity, and glucose homeostasis in zebrafish", FASEB J, 34, pp.1546~1557 (2020)
41. O'Hare EA, "Disruption of ldlr causes increased LDL-C and vascular lipid accumulation in a zebrafish model of hypercholesterolemia", J Lipid Res, 55, pp.2242~2253 (2014)
42. Allayee H, "Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype", Am J Hum Genet, 63, pp.577~585 (1998)
43. Allayee H, "Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia", Circ Res, 92, pp.1262~1267 (2003)
44. Stone NJ, "Secondary causes of hyperlipidemia", Med Clin North Am, 78, pp.117~141 (1994)
45. Baggio G, "Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients", J Clin Invest, 77, pp.520~527 (1986)
46. Millar JS, "Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production", Arterioscler Thromb Vasc Biol, 25, pp.560~565 (2005)
47. Moore KJ, "Macrophages in atherosclerosis : a dynamic balance", Nat Rev Immunol, 13, pp.709~721 (2013)
48. Lee SJ, "Association of early atherosclerosis with vascular wall shear stress in hypercholesterolemic zebrafish", PLoS One, 10, pp.e0142945~ (2015)
49. Thierer JH, "The LipoGlo reporter system for sensitive and specific monitoring of atherogenic lipoproteins", Nat Commun, 10, pp.3426~ (2019)
50. Oka T, "Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity", BMC Physiol, 10, pp.21~ (2010)
51. Kim SH, "High consumption of iron exacerbates hyperlipidemia, atherosclerosis, and female sterility in zebrafish via acceleration of glycation and degradation of serum lipoproteins", Nutrients, 9, pp.690~ (2017)
52. Kopp R, "Bringing obesity to light : rev-erbα, a central player in light-induced adipogenesis in the zebrafish?", Int J Obes, 40, pp.824~832 (2016)
53. Den Broeder MJ, "Zebrafish as a model to study the role of peroxisome proliferating-activated receptors in adipogenesis and obesity", PPAR Res, 2015, pp.358029~ (2015)
54. Liu Z, "A school-based comprehensive intervention for childhood obesity in china : a cluster randomized controlled trial", Child Obes, 15, pp.105~115 (2019)
55. Connelly PW, "Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease", J Clin Invest, 80, pp.1597~1606 (1987)
56. Liu Y, "Effects of genetic variants on lipid parameters and dyslipidemia in a Chinese population", J Lipid Res, 52, pp.354~360 (2011)
57. Kim SH, "A post-developmental genetic screen for zebrafish models of inherited liver disease", PLoS One, 10, pp.e0125980~ (2015)
58. Hugo SE, "A genetic screen for zebrafish mutants with hepatic steatosis identifies a locus required for larval growth", J Anat, 230, pp.407~413 (2017)
59. Sadler KC, "A genetic screen in zebrafish identifies the mutants vps18, nf2 and foie gras as models of liver disease", Development, 132, pp.3561~3572 (2005)
60. Hugo SE, "A genetic model to study increased hexosamine biosynthetic flux", Endocrinology, 158, pp.2420~2426 (2017)
61. Largo R, "Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis", Am J Physiol Heart Circ Physiol, 297, pp.H268~H276 (2009)
62. Stender S, "Glucosamine and experimental atherosclerosis. Increased wet weight and changed composition of cholesterol fatty acids in aorta of rabbits fed a cholesterol-enriched diet with added glucosamine", Atherosclerosis, 26, pp.205~213 (1977)
63. Nasevicius A, "Effective targeted gene ‘knockdown’ in zebrafish", Nat Genet, 26, pp.216~220 (2000)
64. Pinto CL, "Lxr regulates lipid metabolic and visual perception pathways during zebrafish development", Mol Cell Endocrinol, 419, pp.29~43 (2016)
65. Fang L, "Control of angiogenesis by AIBP-mediated cholesterol efflux", Nature, 498, pp.118~122 (2013)
66. Cassar S, "Use of zebrafish in drug discovery toxicology", Chem Res Toxicol, 33, pp.95~118 (2020)
67. Peterson RT, "Small molecule developmental screens reveal the logic and timing of vertebrate development", Proc Natl Acad Sci U S A, 97, pp.12965~12969 (2000)
68. MacRae CA, "Zebrafish as tools for drug discovery", Nat Rev Drug Discov, 14, pp.721~731 (2015)
69. Wiley DS, "Chemical screening in zebrafish for novel biological and therapeutic discovery", Methods Cell Biol, 138, pp.651~679 (2017)
70. Hao J, "In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors", ACS Chem Biol, 5, pp.245~253 (2010)
71. Peterson RT, "Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation", Nat Biotechnol, 22, pp.595~599 (2004)
72. North TE, "Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis", Nature, 447, pp.1007~1011 (2007)
73. Clifton JD, "Identification of novel inhibitors of dietary lipid absorption using zebrafish", PLoS One, 5, pp.e12386~ (2010)
74. Al-Habsi AA, "Exposure to gemfibrozil and atorvastatin affects cholesterol metabolism and steroid production in zebrafish(Danio rerio)", Comp Biochem Physiol B Biochem Mol Biol, 199, pp.87~96 (2016)
75. Golomb BA, "Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism", Am J Cardiovasc Drugs, 8, pp.373~418 (2008)

관련 논문AI추천